(Q50887850)

24 March 2018

review article

1 reference

title

Topiramate. Clinical profile in epilepsy. (English)

1 reference

24 March 2018

author name string

R C Sachdeo

series ordinal

1

1 reference

24 March 2018

publication date

1 May 1998

1 reference

24 March 2018

Clinical Pharmacokinetics

published in

1 reference

24 March 2018

volume

34

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

335-346

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.2165/00003088-199834050-00001

exact match

0 references

cites work

Safety of topiramate: adverse events and relationships to dosing

1 reference

12 December 2020

1 reference

12 December 2020

Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy

1 reference

12 December 2020

Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy

1 reference

12 December 2020

Anticonvulsant effect of topiramate [2,3:4,5-bis-O-(1-methylethylidene-beta-D-fructopyranose sulfate] on amygdaloid kindled seizures in the cat.

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

12 December 2020

Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons

1 reference

12 December 2020

Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials

1 reference

12 December 2020

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

12 December 2020

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

12 December 2020

New antiepileptic drugs

1 reference

12 December 2020

Topiramate: a potent anticonvulsant in the amygdala-kindled rat

1 reference

12 December 2020

Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

12 December 2020

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

12 December 2020

Topiramate: a new antiepileptic drug

1 reference

12 December 2020

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

12 December 2020

Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy

1 reference

12 December 2020

Topiramate monotherapy for partial onset seizures.

1 reference

12 December 2020

Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice

1 reference

12 December 2020

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

12 December 2020

10.2165/00003088-199834050-00001

Identifiers

DOI

1 reference

24 March 2018

Dimensions Publication ID

1039180710

0 references

1 reference

24 March 2018